Prostate Cancer Treatment Shows Promising Data From This Company
GT Biopharma's GTB-5550 Shows Promise in Treating Prostate Cancer.
GT Biopharma recently announced positive preclinical data highlighting the potential of GTB-5550, its novel TriKE molecule, as a targeted treatment for prostate cancer. The data was presented at the 2023 Annual Meeting of the Society for Immunotherapy of Cancer (SITC) held November 1-5 in San Diego.
In precli…